Palantir Reports Record Growth, Raises 2026 Revenue Outlook Above Expectations 
BMW Keeps 2026 Outlook Despite 25% Profit Drop Amid Tariff Pressure 
Supermicro Forecasts Strong Q4 Revenue Growth as AI Server Demand Surges 
Strategy Hints at Bitcoin Sales to Cover Dividends After Massive Q1 Loss 
Samsung Surpasses $1 Trillion Market Cap Amid AI Chip Boom and Apple Partnership Talks 
Hugo Boss Beats Q1 Profit Expectations Despite Market Headwinds 
Hua Hong Semiconductor Stock Surges to Multi-Year High Amid AI Boom 
Anthropic’s $1.5B AI Venture with Wall Street Firms Targets Private Equity Market 
Apple Explores Intel and Samsung Partnerships to Diversify Chip Supply Chain 
Berkshire Hathaway Meeting Sees Shift as Greg Abel Steps Into Leadership Spotlight 
Novo Nordisk Raises 2026 Outlook on Strong Wegovy Demand 
Volvo Car Sales Drop 10% in Early 2026 Despite Growth in Electric Vehicles 
Continental AG Shares Jump After Q1 Profit Beats Expectations 
Anthropic Secures $1.5B AI Venture Backed by Wall Street Giants, Shaking Software Sector 
NAB First-Half Earnings Miss Forecasts Amid Rising Global Risks 
Lufthansa Q1 Loss Narrows as Strong Summer Travel Demand Boosts Outlook 
CUPERTINO, CA, May 04, 2018 -- Aemetis, Inc. (NASDAQ: AMTX) today announced that Eric McAfee, Chairman and CEO, is scheduled to present on Wednesday, May 9, 2018 at the Disruptive Growth & Healthcare Conference in New York. The conference will be held at the Reed Smith office in New York City.
About Aemetis
Headquartered in Cupertino, California, Aemetis is an advanced renewable fuels and biochemicals company focused on the acquisition, development and commercialization of innovative technologies that replace traditional petroleum-based products by the conversion of ethanol and biodiesel plants into advanced biorefineries. Founded in 2006, Aemetis owns and operates a 60 million gallon per year ethanol production facility in California’s Central Valley, near Modesto. Aemetis also owns and operates a 50 million gallon per year renewable chemical and advanced fuel production facility on the East Coast of India producing high quality distilled biodiesel and refined glycerin for customers in India, the US and Europe. Aemetis operates a research and development laboratory, and holds a portfolio of patents and related technology licenses for the production of renewable fuels and biochemicals. For additional information about Aemetis, please visit www.aemetis.com.
External Investor Relations
Contact:
Kirin Smith
PCG Advisory Group
(646) 863-6519
Company Investor Relations/
Media Contact:
Todd Waltz
(408) 213-0940
